When.com Web Search

  1. Ads

    related to: multiple myeloma progression free survival rate table

Search results

  1. Results From The WOW.Com Content Network
  2. Multiple myeloma - Wikipedia

    en.wikipedia.org/wiki/Multiple_myeloma

    MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5–1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.

  3. POEMS syndrome - Wikipedia

    en.wikipedia.org/wiki/POEMS_syndrome

    Toggle the table of contents ... Multiple myeloma is usually diagnosed because malignant plasma cells ... the Mayo Clinic reported progression-free survival rates of ...

  4. Ixazomib - Wikipedia

    en.wikipedia.org/wiki/Ixazomib

    In this study, ixazomib increased the median time of progression-free survival from 14.7 months (in the placebo+lenalidomide+dexamethasone study arm including 362 people) to 20.6 months (under ixazomib+lenalidomide+dexamethasone, 360 people), which was a statistically significant effect (p = 0.012). 11.7% of patients in the ixazomib group had a ...

  5. Waldenström macroglobulinemia - Wikipedia

    en.wikipedia.org/wiki/Waldenström_macroglobulinemia

    Five-year survival rates for these categories are 87%, 68%, and 36%, respectively. [82] The corresponding median survival rates are 12, 8, and 3.5 years. [83] The International Prognostic Scoring System for Waldenström's Macroglobulinemia has been shown to be reliable. [84] It is also applicable to patients on a rituximab-based treatment ...

  6. Plasmacytoma - Wikipedia

    en.wikipedia.org/wiki/Plasmacytoma

    Most cases of SPB progress to multiple myeloma within 2–4 years of diagnosis, but the overall median survival for SPB is 7–12 years. 30–50% of extramedullary plasmacytoma cases progress to multiple myeloma with a median time of 1.5–2.5 years. 15–45% of SPB and 50–65% of extramedullary plasmacytoma are disease free after 10 years. [3]

  7. Progression-free survival - Wikipedia

    en.wikipedia.org/wiki/Progression-free_survival

    Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology , PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically.

  1. Ad

    related to: multiple myeloma progression free survival rate table